IL5 and Increased total eosinophil count: At present, our data suggest that high β2-agonist reversibility might not be the best predictor of response to anti-IL-5 treatment while low β2-reversibility (in the presence of a marked eosinophilia) might be indicative of eosinophil-dependent asthma.